ConductScience.org, home

Paper · 39200293

Exploring the Role of Hormones and Cytokines in Osteoporosis Development.

Umur E and 8 others. Biomedicines, 2024. Cited by 41 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Exploring the Role of Hormones and Cytokines in Osteoporosis Development. Papers, record 39200293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39200293

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploring the Role of Hormones and Cytokines in Osteoporosis Development.
PubMed
Journal
Biomedicines
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
8.65, provisional
iCite
Revised in PubMed
2024-09-01
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Umur EEgemenhttps://orcid.org/0009-0004-9195-3305
2Bulut SBSafiye Betülhttps://orcid.org/0000-0003-1083-5047
3Yiğit PPelinhttps://orcid.org/0000-0002-2126-3868
4Bayrak EEmirhanhttps://orcid.org/0000-0003-1600-4762
5Arkan YYaren
6Arslan FFahriye
7Baysoy EEngin
8Kaleli-Can GGizemhttps://orcid.org/0000-0002-4411-622X
9Ayan BBugrahttps://orcid.org/0000-0003-4614-263X

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References365

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19,783,546Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood.J Bone Miner Res1998https://conductscience.org/library/papers/9783546PubMed
210,936,147Proinflammatory cytokines.Chest2000https://conductscience.org/library/papers/10936147PubMed
319,539,794Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.Bone2009https://conductscience.org/library/papers/19539794PubMed
410,358,772The IL-4 receptor: signaling mechanisms and biologic functions.Annu Rev Immunol1999https://conductscience.org/library/papers/10358772PubMed
529,942,929Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease.J Endocr Soc2018https://conductscience.org/library/papers/29942929PubMed
69,389,739Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha.J Clin Invest1997https://conductscience.org/library/papers/9389739PubMed
722,161,825The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology.Int J Dev Biol2011https://conductscience.org/library/papers/22161825PubMed
818,450,470The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.Cytokine2008https://conductscience.org/library/papers/18450470PubMed
91,831,327Human osteoblasts synthesize and respond to platelet-derived growth factor.Am J Physiol1991https://conductscience.org/library/papers/1831327PubMed
1031,404,890Interleukin-35 stimulates tumor necrosis factor-α activated osteoblasts differentiation through Wnt/β-catenin signaling pathway in rheumatoid arthritis.Int Immunopharmacol2019https://conductscience.org/library/papers/31404890PubMed

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42,761,519Targeting subchondral osteoporosis in osteoarthritis: biomechanical crosstalk and the therapeutic rationale for inflammatory microenvironment remodeling.Front Immunol2026https://conductscience.org/library/papers/42761519PubMed
42,666,577Retrospective Development and Internal Validation of a Diagnostic Model to Identify Secondary Osteoporosis in Community-Dwelling Older Men.Orthop Res Rev2026https://conductscience.org/library/papers/42666577PubMed
42,312,209Stress-induced IL-6 regulation in pediatric bone growth disorders: current insights and therapeutic strategies.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42312209PubMed
42,199,525Cellular signaling crosstalk between osteoporosis and diabetes: Common mechanisms and therapeutic targets (Review).Biomed Rep2026https://conductscience.org/library/papers/42199525PubMed
41,987,774Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and osteoporotic fracture.Front Med (Lausanne)2026https://conductscience.org/library/papers/41987774PubMed
41,976,789Glucocorticoid-Induced Osteoporosis: Pathogenesis, the Impact of Different Administration Routes on Bone Mineral Density, and Fracture Risk and Treatment Options-A Narrative Review.J Clin Med2026https://conductscience.org/library/papers/41976789PubMed
41,852,468The role and mechanisms of bone microenvironment regulators in osteoporosis: novel intervention strategies for addressing the challenges of aging.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41852468PubMed
41,833,304Ergothioneine prevents ovariectomy-induced osteoporosis by suppressing NF-κB/p65 signalling to attenuate osteoclastogenesis and bone marrow inflammation.Bone Joint Res2026https://conductscience.org/library/papers/41833304PubMed
41,827,986Osteoimmunologic and Immune-Aging Signatures in Postmenopausal Women with Periodontitis and Low Bone Mineral Density: A Cross-Sectional Study.Diagnostics (Basel)2026https://conductscience.org/library/papers/41827986PubMed
41,810,100HUC-MSC secretome and Nanoemulsion Propolis synergistically modulate inflammatory responses in hyperglycemia-induced calvarial osteolysis.J Oral Biol Craniofac Res2026https://conductscience.org/library/papers/41810100PubMed

1 to 10 of 33

See all 33 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
TNFRSF11B4,982PubTator's text mininghttps://conductscience.org/library/genes/4982NCBI Gene
TNFSF118,600PubTator's text mininghttps://conductscience.org/library/genes/8600NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39200293

GET https://conductscience.org/api/papers/v1/39200293/references?page=2